Concepedia

Publication | Open Access

Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study

37

Citations

22

References

2023

Year

Abstract

In children aged 6-11 years with moderate-to-severe type 2 asthma, dupilumab treatment was associated with rapid, sustained improvements in asthma control. HRQoL was significantly improved for children and their caregivers.

References

YearCitations

Page 1